X0306 4 2019-09-10 0001613103 Medtronic plc MDT 0001610035 HAKAMI HOOMAN 710 MEDTRONIC PKWY MS LC300 MINNEAPOLIS MN 55432 1 EVP & Group President Diabetes Ordinary Shares 2019-09-10 4 S 0 10000 107.085 D 30761 D Ordinary Shares 2019-09-10 4 M 0 10257 78.00 A 41018 D Ordinary Shares 2019-09-10 4 S 0 10257 107.307 D 30761 D Ordinary Shares 2019-09-10 4 M 0 321 78.00 A 31082 D Ordinary Shares 2019-09-10 4 S 0 321 107.22 D 30761 D Ordinary Shares 2019-09-10 4 M 0 27254 88.06 A 58015 D Ordinary Shares 2019-09-10 4 S 0 27254 107.282 D 30761 D Ordinary Shares 2019-09-10 4 M 0 852 88.06 A 31613 D Ordinary Shares 2019-09-10 4 S 0 852 107.22 D 30761 D Ordinary Shares 2019-09-10 4 M 0 19054 83.97 A 49815 D Ordinary Shares 2019-09-10 4 S 0 19054 107.414 D 30761 D Ordinary Shares 2019-09-10 4 M 0 595 83.97 A 31356 D Ordinary Shares 2019-09-10 4 S 0 595 107.22 D 30761 D Ordinary Shares 2019-09-10 4 M 0 14121 89.08 A 44882 D Ordinary Shares 2019-09-10 4 S 0 14121 107.412 D 30761 D Ordinary Shares 2019-09-10 4 M 0 423 89.08 A 31184 D Ordinary Shares 2019-09-10 4 S 0 423 107.22 D 30761 D Stock Option (Right to Buy) 78.00 2019-09-10 4 M 0 10257 0 D 2016-08-03 2025-08-03 Ordinary Shares 10257 321 D Stock Option (Right to Buy) 78.00 2019-09-10 4 M 0 321 0 D 2016-08-03 2025-08-03 Ordinary Shares 321 0 D Stock Option (Right to Buy) 88.06 2019-09-10 4 M 0 27254 0 D 2017-08-01 2026-08-01 Ordinary Shares 27254 9085 D Stock Option (Right to Buy) 88.06 2019-09-10 4 M 0 852 0 D 2017-08-01 2026-08-01 Ordinary Shares 852 284 D Stock Option (Right to Buy) 83.97 2019-09-10 4 M 0 19054 0 D 2018-07-31 2027-07-31 Ordinary Shares 19054 19055 D Stock Option (Right to Buy) 83.97 2019-09-10 4 M 0 595 0 D 2018-07-31 2027-07-31 Ordinary Shares 595 596 D Stock Option (Right to Buy) 89.08 2019-09-10 4 M 0 14121 0 D 2019-07-30 2028-07-30 Ordinary Shares 14121 42364 D Stock Option (Right to Buy) 89.08 2019-09-10 4 M 0 423 0 D 2019-07-30 2028-07-30 Ordinary Shares 423 1272 D The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $107.00 to $107.39, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $107.10 to $107.43, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $107.07 to $107.47, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $107.28 to $107.58, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $107.36 to $107.48, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. These options to purchase ordinary shares of New Medtronic for $62.76 per share, which were unvested at the effective time of the Merger, were received in the Merger and represent the conversion of an equal number of Medtronic common stock shares for $62.76 per share. The New Medtronic stock option has the same terms and conditions as the original Medtronic stock option. These options became exercisable in four equal annual installments beginning on July 28, 2015, which was the first anniversary of the grant. /s/ Perry F. Sekus, attorney-in-fact 2019-09-12